SE7613851L - Glukosaminderivat - Google Patents

Glukosaminderivat

Info

Publication number
SE7613851L
SE7613851L SE7613851A SE7613851A SE7613851L SE 7613851 L SE7613851 L SE 7613851L SE 7613851 A SE7613851 A SE 7613851A SE 7613851 A SE7613851 A SE 7613851A SE 7613851 L SE7613851 L SE 7613851L
Authority
SE
Sweden
Prior art keywords
glucosamine derivatives
increase
glucosamine
derivatives
carboxymethylglucopyranosides
Prior art date
Application number
SE7613851A
Other languages
English (en)
Other versions
SE445923B (sv
Inventor
G Baschang
A Hartmann
J Stanek
A Sele
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of SE7613851L publication Critical patent/SE7613851L/sv
Publication of SE445923B publication Critical patent/SE445923B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE7613851A 1975-12-10 1976-12-09 Forfarande for framstellning av glukosaminderivat SE445923B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1604275A CH613709A5 (en) 1975-12-10 1975-12-10 Process for the preparation of glucosamine derivatives

Publications (2)

Publication Number Publication Date
SE7613851L true SE7613851L (sv) 1977-06-11
SE445923B SE445923B (sv) 1986-07-28

Family

ID=4414012

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7613851A SE445923B (sv) 1975-12-10 1976-12-09 Forfarande for framstellning av glukosaminderivat

Country Status (30)

Country Link
JP (1) JPS5273820A (sv)
AR (2) AR224091A1 (sv)
AT (1) AT365607B (sv)
AU (1) AU508764B2 (sv)
BE (1) BE849214A (sv)
CA (1) CA1262400A (sv)
CH (2) CH613709A5 (sv)
CS (4) CS205025B2 (sv)
DD (1) DD129781A5 (sv)
DE (1) DE2655500A1 (sv)
DK (1) DK154654C (sv)
ES (2) ES454118A1 (sv)
FI (1) FI64164C (sv)
FR (1) FR2361902A1 (sv)
GB (1) GB1570625A (sv)
GR (1) GR61647B (sv)
HK (1) HK32883A (sv)
HU (1) HU177970B (sv)
IE (1) IE44190B1 (sv)
IL (1) IL51076A (sv)
MY (1) MY8400123A (sv)
NL (1) NL7613666A (sv)
NO (1) NO144850C (sv)
NZ (1) NZ182837A (sv)
PL (4) PL110353B1 (sv)
PT (1) PT65946B (sv)
SE (1) SE445923B (sv)
SG (1) SG11083G (sv)
SU (3) SU660589A3 (sv)
ZA (1) ZA767333B (sv)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
US4370265A (en) * 1974-10-22 1983-01-25 Agence Nationale De Valorisation Water soluble agents effective as immunological adjuvants for stimulating in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
GB1571133A (en) * 1976-04-26 1980-07-09 Syntex Inc Immuniological adjuvant peptidoglycans compounds and methods of preparation thereof
EP0002677B1 (en) 1977-12-02 1982-10-13 Takeda Chemical Industries, Ltd. Glucosamine-peptide derivatives and their pharmaceutical compositions
EP0003833B2 (de) * 1978-02-24 1990-12-19 Ciba-Geigy Ag Antigenderivate, Verfahren zu deren Herstellung, diese enthaltende pharmazeutische Präparate
US4397844A (en) * 1978-02-24 1983-08-09 Ciba-Geigy Corporation Antigen derivatives and processes for their preparation
FR2420545A1 (fr) * 1978-03-20 1979-10-19 Anvar Nouveaux esters de l'acide n-acetyl-muramyl-aminoacyl-glutamique ou des derives de substitution de celui-ci a proprietes anti-infectieuses et/ou d'adjuvants immunologiques
FR2442241A2 (fr) * 1978-03-20 1980-06-20 Anvar Nouveaux composes esters de muramyl-peptide, leur preparation et les compositions pharmaceutiques les contenant, notamment sous forme de liposomes
FR2428051A1 (fr) * 1978-06-05 1980-01-04 Anvar Nouveaux composes du type muramyl-peptide et medicaments les contenant
FR2428050A1 (fr) * 1978-06-05 1980-01-04 Anvar Oligomeres de composes du type muramyl-peptide et medicaments les contenant
FR2446292A1 (fr) * 1979-01-12 1980-08-08 Anvar Muramyl-peptides fixes sur polymeres peptidiques et medicaments les contenant
US4256735A (en) * 1979-01-29 1981-03-17 Merck & Co., Inc. Immunologically active dipeptidyl saccharides and methods of preparation
FR2449697A1 (fr) 1979-02-20 1980-09-19 Anvar Nouveaux muramyl-peptides substitues sur un azote peptidique et medicaments les contenant
JPS55111499A (en) * 1979-02-21 1980-08-28 Takeda Chem Ind Ltd Glucosamine derivative and its preparation
JPS5618996A (en) * 1979-06-21 1981-02-23 Dai Ichi Seiyaku Co Ltd Muramyldipeptide derivative
FI75578C (sv) * 1979-07-25 1988-07-11 Ciba Geigy Ag Analogiförfarande för framställning av farmakologiskt verkande lipofil a fosfatidylmuramylpeptider.
JPS5649396A (en) * 1979-09-28 1981-05-02 Dai Ichi Seiyaku Co Ltd Novel muramyldipeptide derivative
EP0026746B1 (de) * 1979-10-02 1985-04-10 Ciba-Geigy Ag Kombinationspräparate zur Anwendung in einem Verfahren zur Steigerung der Wirkung von Antibiotika, antibiotische Präparate mit gesteigerter Wirksamkeit und Verfahren zu deren Herstellung
FI803077A (fi) * 1979-10-12 1981-04-13 Ciba Geigy Ag Foerfarande foer framstaellning av myramylpeptider
US4409209A (en) * 1979-10-12 1983-10-11 Ciba-Geigy Corporation Novel phosphorylmuramyl peptides and processes for the manufacture thereof
US4406889A (en) * 1980-02-15 1983-09-27 Ciba-Geigy Corporation Derivatives of aldohexoses, intermediates, processes for their manufacture, preparations containing such compounds, and their use
US4368190A (en) * 1980-04-17 1983-01-11 Merck & Co., Inc. Immunologically active dipeptidyl 4-O-,6-O-acyl-2-amino-2-deoxy-D-glucose derivatives and methods for their preparation
US4310514A (en) 1980-05-05 1982-01-12 Merck & Co., Inc. Immunologically active dipeptidyl 5-0,6-0-acyl-2-amino-2-deoxy-D-glucofuranose derivatives and methods of preparation
EP0056560A1 (de) * 1981-01-19 1982-07-28 Ciba-Geigy Ag Antibiotische Präparate mit gesteigerter Wirksamkeit, Verfahren zu deren Herstellung und Verfahren zur Steigerung der antibiotischen Wirkung von Antibiotika
GR78246B (sv) * 1981-01-23 1984-09-26 Ciba Geigy Ag
JPS6042398A (ja) * 1983-08-18 1985-03-06 Toshiyuki Hamaoka ムラミルジペプチド活性エステル誘導体
EP0541486A1 (de) * 1991-11-07 1993-05-12 Ciba-Geigy Ag Polycyclische Konjugate
JP4875612B2 (ja) * 2005-04-27 2012-02-15 真司 武岡 カチオン性アミノ酸型脂質
US10610564B2 (en) 2015-02-26 2020-04-07 Stc.Unm IRGM and precision autophagy controls for antimicrobial and inflammatory disease states and methods of detection of autophagy
CN108884132B (zh) * 2015-12-10 2022-10-04 巴拉特生物技术国际有限公司 胞壁酰肽衍生物化合物、其合成及其用途
CN108883080B (zh) * 2015-12-15 2021-12-21 巴拉特生物技术国际有限公司 胞壁酰肽衍生物化合物、其合成及其用途
WO2019040109A1 (en) 2017-08-21 2019-02-28 Celgene Corporation PROCESSES FOR THE PREPARATION OF (S) -TERT-BUTYL 4,5-DIAMINO-5-OXOPENTANOATE

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents

Also Published As

Publication number Publication date
FI64164B (fi) 1983-06-30
FI64164C (fi) 1983-10-10
AR224091A1 (es) 1981-10-30
NO764191L (sv) 1977-06-13
ZA767333B (en) 1977-11-30
CS205027B2 (en) 1981-04-30
FR2361902B1 (sv) 1980-11-07
SE445923B (sv) 1986-07-28
AR220686A1 (es) 1980-11-28
CS205026B2 (en) 1981-04-30
NL7613666A (nl) 1977-06-14
PL194291A1 (pl) 1978-10-23
PL110794B1 (en) 1980-07-31
DK552476A (da) 1977-06-11
IE44190L (en) 1977-06-10
PT65946B (en) 1978-06-14
HK32883A (en) 1983-09-02
SU747430A3 (ru) 1980-07-23
ES465514A1 (es) 1978-09-16
SU1060118A3 (ru) 1983-12-07
AU2042276A (en) 1978-06-15
ES454118A1 (es) 1978-03-01
IL51076A0 (en) 1977-02-28
AT365607B (de) 1982-02-10
FI763541A (sv) 1977-06-11
DE2655500A1 (de) 1977-06-23
FR2361902A1 (fr) 1978-03-17
PT65946A (en) 1977-01-01
IE44190B1 (en) 1981-09-09
PL110353B1 (en) 1980-07-31
CA1262400A (en) 1989-10-17
DD129781A5 (de) 1978-02-08
CS205028B2 (en) 1981-04-30
MY8400123A (en) 1984-12-31
GB1570625A (en) 1980-07-02
GR61647B (en) 1978-12-05
NO144850B (no) 1981-08-17
BE849214A (fr) 1977-06-09
HU177970B (en) 1982-02-28
NO144850C (no) 1981-11-25
JPS5273820A (en) 1977-06-21
DK154654B (da) 1988-12-05
PL110787B1 (en) 1980-07-31
DK154654C (da) 1989-05-08
CS205025B2 (en) 1981-04-30
CH613709A5 (en) 1979-10-15
PL112672B1 (en) 1980-10-31
ATA909276A (de) 1981-06-15
AU508764B2 (en) 1980-04-03
SU660589A3 (ru) 1979-04-30
DE2655500C2 (sv) 1988-12-22
SG11083G (en) 1983-09-16
IL51076A (en) 1980-09-16
JPS638118B2 (sv) 1988-02-19
CH614718A5 (en) 1979-12-14
NZ182837A (en) 1978-07-28

Similar Documents

Publication Publication Date Title
SE7613851L (sv) Glukosaminderivat
DE69331901T2 (de) Impfstoff auf urease-basis gegen helicobacter infektionen
ATE116993T1 (de) Saponin-hilfsmittel.
SE9102976L (sv) Hybrid dna vektorer, encelliga organismer och bakterier till anvaendning foer produktion av hiv-proteiner och peptider
ATE326231T1 (de) Mutierendes enterotoxin als nichttoxisches orales adjuvans
DE69131200T2 (de) Herpes simplex virus vp16 impfstoffe
SE7511794L (sv) Fergemne
ES379641A1 (es) Procedimiento de produccion de antigenos inactivos para preparados farmaceuticos.
EP0048422A3 (en) Pili of pseudomonas aeruginosa and utilization of same as vaccines against infectionary p.aeruginosa
DK313587D0 (da) Tetrahydrobenzothiazolforbindelser, deres fremstilling og anvendelse
NO913131L (no) Immunogene konjugater av ikke-toksisk oligosakkarid fra bordetella pertussis lipoolysakkarid.
ATE385809T1 (de) Saponin-zusammensetzungen und deren verwendung
ATE16348T1 (de) Ozon-inaktivierte keime als vakzine.
DE59106398D1 (de) Oligophosphate mit antiviraler Wirkung.
GB1085798A (en) Vaccine for combating salmonella infections
GB949400A (en) Poliomyelitis vaccines
FR2287912A1 (fr) Derives de polysaccharide portant des groupements amines, leurs procedes de preparation et leurs applications en tant qu'agents adjuvants de l'immunite non specifique
Umetani Studies on the Vaccine of Rickettsia tsutsugamushi I: Influences of Storage conditions on the Immunogenicity of the Vaccine of Rickettsia tsutsugamushi
SU1739559A1 (ru) Штамм вируса aphtae epizooticae типа o, используемый для изготовления диагностических сывороток и антигенных препаратов
GB949399A (en) Poliomyelitis vaccines
JPS525795A (en) Preparation of tetrahydro pyridopyrimidinone derivatives
SU681928A1 (ru) Адъювант
FR2088258A2 (en) Benzophenone cyclic acetals prepn
CA607992A (en) Stable poliomyelitis live virus vaccine
GB1036283A (en) A substituted amide

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7613851-0

Effective date: 19940710

Format of ref document f/p: F